(Q44503619)

3 December 2017

title

Subgingival microbial profiles in refractory periodontal disease (English)

1 reference

3 December 2017

Sigmund S Socransky

1

1 reference

3 December 2017

Claire Smith

series ordinal

2

1 reference

3 December 2017

Anne D Haffajee

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Journal of Clinical Periodontology

3 December 2017

published in

1 reference

3 December 2017

volume

29

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

260-268

1 reference

Serum IgG2 level, Gm(23) allotype and FcgammaRIIa and FcgammaRIIIb receptors in refractory periodontal disease

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

Clinical and microbiological features of refractory periodontitis subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

Serum antibodies reacting with subgingival species in refractory periodontitis subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

Efficacy of clindamycin hydrochloride in refractory periodontitis. 12-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

Microbial complexes in subgingival plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

Microbiological and Clinical Results of Metronidazole Plus Amoxicillin Therapy in Actinobacillus actinomycetemcomitans‐Associated Periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically-administered amoxicillin or metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

7 January 2021

Clinical, microbiological and immunological features of subjects with refractory periodontal diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

7 January 2021

Treatment of subjects with refractory periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

7 January 2021

Clinical, microbiological and immunological characteristics of subjects with "refractory" periodontal disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

7 January 2021

Relation of counts of microbial species to clinical status at the sampled site

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

7 January 2021

Effects of metronidazole in patients with "refractory" periodontitis associated with Bacteroides forsythus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-051X.2002.290313.X

7 January 2021

10.1034/J.1600-051X.2002.290313.X

Identifiers

DOI

1 reference

3 December 2017

1 reference